Down another 1.5 % What's next?
Production jobs filled - soon. That press release will be a doozy. Double or triple on that alone.
Sell a voucher soon. That PR, although fully expected, will quadruple price prolly, Newcamo bud!
Select an indication from huge preclinical pipeline by 2022.
submit IND on new indication H1 22
submit trial design phase 1 H2 22
do phase 1 trial H1 23
woooooooooooooooooooooioooooo
